| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.3 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.3 |